183 related articles for article (PubMed ID: 11184062)
1. Acquired immunodeficiency syndrome wasting, functional performance, and quality of life.
Roubenoff R
Am J Manag Care; 2000 Sep; 6(9):1003-16. PubMed ID: 11184062
[TBL] [Abstract][Full Text] [Related]
2. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
Gelato M; McNurlan M; Freedland E
Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
[TBL] [Abstract][Full Text] [Related]
3. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
4. Weight loss and wasting in patients infected with human immunodeficiency virus.
Grinspoon S; Mulligan K;
Clin Infect Dis; 2003 Apr; 36(Suppl 2):S69-78. PubMed ID: 12652374
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.
Schambelan M; Mulligan K; Grunfeld C; Daar ES; LaMarca A; Kotler DP; Wang J; Bozzette SA; Breitmeyer JB
Ann Intern Med; 1996 Dec; 125(11):873-82. PubMed ID: 8967667
[TBL] [Abstract][Full Text] [Related]
6. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
[TBL] [Abstract][Full Text] [Related]
7. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer.
Segal RJ; Reid RD; Courneya KS; Malone SC; Parliament MB; Scott CG; Venner PM; Quinney HA; Jones LW; D'Angelo ME; Wells GA
J Clin Oncol; 2003 May; 21(9):1653-9. PubMed ID: 12721238
[TBL] [Abstract][Full Text] [Related]
8. Effect of recombinant human growth hormone on exercise capacity in patients with HIV-associated wasting on HAART.
Evans WJ; Kotler DP; Staszewski S; Griffin GE; Isgaard J; Gertner JM; O'Brien F; Svanberg E
AIDS Read; 2005 Jun; 15(6):301-3, 306-8, 310, 314. PubMed ID: 15962453
[TBL] [Abstract][Full Text] [Related]
9. Exercise and the treatment of wasting: aging and human immunodeficiency virus infection.
Evans WJ; Roubenoff R; Shevitz A
Semin Oncol; 1998 Apr; 25(2 Suppl 6):112-22. PubMed ID: 9625393
[TBL] [Abstract][Full Text] [Related]
10. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Mulligan K; Zackin R; Clark RA; Alston-Smith B; Liu T; Sattler FR; Delvers TB; Currier JS; ;
Arch Intern Med; 2005 Mar; 165(5):578-85. PubMed ID: 15767536
[TBL] [Abstract][Full Text] [Related]
11. Single-agent/combination therapy of human immunodeficiency virus-related wasting.
Wanke C
Semin Oncol; 1998 Apr; 25(2 Suppl 6):98-103. PubMed ID: 9625391
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial.
Waters D; Danska J; Hardy K; Koster F; Qualls C; Nickell D; Nightingale S; Gesundheit N; Watson D; Schade D
Ann Intern Med; 1996 Dec; 125(11):865-72. PubMed ID: 8967666
[TBL] [Abstract][Full Text] [Related]
13. Anabolic growth hormone action improves submaximal measures of physical performance in patients with HIV-associated wasting.
Esposito JG; Thomas SG; Kingdon L; Ezzat S
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E494-503. PubMed ID: 15886228
[TBL] [Abstract][Full Text] [Related]
14. Effects of a multidisciplinary inpatient intervention on body composition, aerobic fitness, and quality of life in severely obese girls and boys.
Knöpfli BH; Radtke T; Lehmann M; Schätzle B; Eisenblätter J; Gachnang A; Wiederkehr P; Hammer J; Brooks-Wildhaber J
J Adolesc Health; 2008 Feb; 42(2):119-27. PubMed ID: 18207089
[TBL] [Abstract][Full Text] [Related]
15. Testosterone replacement for hypogonadism: clinical findings and best practices.
Hengge UR
AIDS Read; 2003 Dec; 13(12 Suppl):S15-21. PubMed ID: 14959695
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial evaluating nutrition counseling with or without oral supplementation in malnourished HIV-infected patients.
Rabeneck L; Palmer A; Knowles JB; Seidehamel RJ; Harris CL; Merkel KL; Risser JM; Akrabawi SS
J Am Diet Assoc; 1998 Apr; 98(4):434-8. PubMed ID: 9550167
[TBL] [Abstract][Full Text] [Related]
17. The effect of resistance training on functional capacity and quality of life in individuals with high and low numbers of metabolic risk factors.
Levinger I; Goodman C; Hare DL; Jerums G; Selig S
Diabetes Care; 2007 Sep; 30(9):2205-10. PubMed ID: 17563342
[TBL] [Abstract][Full Text] [Related]
18. A team approach to the treatment of AIDS wasting.
Abbaticola MM
J Assoc Nurses AIDS Care; 2000; 11(1):45-56. PubMed ID: 10670006
[TBL] [Abstract][Full Text] [Related]
19. Counteracting muscle wasting in HIV-infected individuals.
Dudgeon WD; Phillips KD; Carson JA; Brewer RB; Durstine JL; Hand GA
HIV Med; 2006 Jul; 7(5):299-310. PubMed ID: 16945075
[TBL] [Abstract][Full Text] [Related]
20. Weight loss, wasting, and survival in HIV-positive patients: current strategies.
Tang AM
AIDS Read; 2003 Dec; 13(12 Suppl):S23-7. PubMed ID: 14959696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
